The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

2003 • 3,816 citations

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

2008 • 3,396 citations

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

2001 • 3,093 citations

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

2001 • 3,065 citations

Treatment of Hypertension in Patients 80 Years of Age or Older

2008 • 2,927 citations

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

2003 • 2,653 citations

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1999 • 2,051 citations

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

1998 • 2,003 citations

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

2007 • 1,978 citations

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials

2000 • 1,789 citations

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

2008 • 1,539 citations

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study

2002 • 1,517 citations

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1999 • 1,472 citations

Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement

2004 • 1,377 citations

Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents

2003 • 1,103 citations

CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

2003 • 1,046 citations

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

2008 • 953 citations

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

2005 • 811 citations

Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention

2005 • 767 citations

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services

2004 • 760 citations

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

2008 • 747 citations

Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease

2008 • 702 citations

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials

1999 • 644 citations

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

2004 • 539 citations

Completeness of Safety Reporting in Randomized Trials

2001 • 537 citations

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

2003 • 475 citations

Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation

2000 • 451 citations

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

2005 • 381 citations

Introduction

2006 • 263 citations

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

2008 • 230 citations

Blood Pressure and Survival in the Oldest Old

2007 • 178 citations

Smoking and the Risk of Incident Hypertension in Middle-aged and Older Men

2008 • 156 citations

Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.

1992 • 150 citations

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II – Therapy

2006 • 139 citations

Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis

2008 • 113 citations

The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.

2004 • 93 citations

The 2004 Canadian recommendations for the management of hypertension: Part III--Lifestyle modifications to prevent and control hypertension.

2004 • 89 citations

Regional variation in self-reported heart disease prevalence in Canada.

2005 • 82 citations

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

2005 • 70 citations

Risk of hypertension amongst Swedish male snuff users: a prospective study

2008 • 66 citations

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

2002 • 61 citations

The Canadian Hypertension Education Program – A unique Canadian initiative

2006 • 60 citations

Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence

2006 • 53 citations

Atrial Fibrillation and Isolated Systolic Hypertension

2008 • 47 citations

The 2000 Canadian recommendations for the management of hypertension: Part one--therapy.

2001 • 37 citations

Making hypertensive smokers motivated in quitting: developing ‘blood pressure equivalence of smoking’

2008 • 7 citations

Differences in need for antihypertensive drugs among those aware and unaware of their hypertensive status: a cross sectional survey

2005 • 5 citations

Cited By (0)

Loading...